Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
14 studies found for:    Open Studies | "Hypoparathyroidism"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Hypoparathyroidism" (14 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Effects of PTH Replacement on Bone in Hypoparathyroidism
Conditions: Hypoparathyroidism;   DiGeorge Syndrome
Interventions: Drug: Parathyroid Hormone 1-34;   Drug: PTH 1-34
2 Recruiting PARADIGHM A Natural History Registry for Patients With Chronic Hypoparathyroidism
Condition: Chronic Hypoparathyroidism
Intervention: Other: None [Natural history registry]
3 Not yet recruiting A Pilot Study to Assess the Safety and Efficacy of Oral PTH (1-34) in the Treatment of Hypoparathyroidism
Condition: Hypoparathyroidism
Intervention: Drug: EnteraBio's Oral Parathyroid Hormone (1-34)
4 Not yet recruiting A Study Comparing Amorphous Calcium Carbonate (ACC) Versus Crystalline Calcium CCS) in Hypoparathyroidism Patients
Condition: Hypoparathyroidism
Interventions: Dietary Supplement: amorphous calcium carbonate;   Dietary Supplement: crystalline calcium supplements
5 Unknown  Vitamin D Levels and Postoperative Hypocalcemia After Total Thyroidectomy
Conditions: Hypocalcemia;   Hypoparathyroidism;   Vitamin D Deficiency;   Thyroidectomy
Intervention:
6 Unknown  Genetics and Psychopathology in the 22q11 Deletion Syndrome
Condition: Chromosome 22q11.2 Deletion Syndrome
Intervention:
7 Unknown  Genetic Modifiers for 22q11.2 Syndrome
Condition: 22q11.2 Deletion Syndrome
Intervention: Other: Observation
8 Recruiting Immune Disorder HSCT Protocol
Conditions: Immune Deficiency Disorders:;   Severe Combined Immunodeficiency;   Chronic Granulomatous Disease;   X-linked Agammaglobulinemia;   Wiskott-Aldrich Syndrome;   Hyper-IgM;   DiGeorge Syndrome;   Chediak-Higashi Syndrome;   Common Variable Immune Deficiency;   Immune Dysregulatory Disorder:;   Hemophagocytic Lymphohistiocytosis;   IPEX;   Autoimmune Lymphoproliferative Syndrome;   X-linked Lymphoproliferative Syndrome
Intervention: Drug: Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan
9 Unknown  The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome
Conditions: Velocardiofacial Syndrome;   Williams Syndrome;   Fragile X Syndrome
Intervention: Drug: methylphenidate, fluoxetin, risperidone
10 Recruiting Thymus Transplantation Safety-Efficacy
Conditions: Complete DiGeorge Anomaly;   DiGeorge Syndrome;   DiGeorge Anomaly;   Complete DiGeorge Syndrome
Interventions: Biological: Thymus  Tissue for Transplantation;   Procedure: Blood Draw;   Drug: Rabbit anti-thymocyte globulin;   Drug: Cyclosporine;   Drug: Tacrolimus;   Drug: Methylprednisolone or Prednisolone;   Drug: Basiliximab;   Drug: Mycophenolate mofetil
11 Unknown  Immunologic Evaluation in Patients With DiGeorge Syndrome or Velocardiofacial Syndrome
Conditions: DiGeorge Syndrome;   Shprintzen Syndrome;   Chromosome Abnormalities;   Abnormalities, Multiple;   Conotruncal Cardiac Defects
Intervention:
12 Unknown  Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome
Conditions: DiGeorge Syndrome;   22q11.2 Deletion Syndrome
Intervention:
13 Not yet recruiting Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome.
Condition: 22q11 Deletion Syndrome
Interventions: Dietary Supplement: omega-3 PUFAs;   Other: Standard care;   Dietary Supplement: placebo
14 Recruiting A Study to Determine the Effects of NPSP795 on the Calcium-sensing Receptor in Subjects With Autosomal Dominant Hypocalcemia as Measured by PTH Levels and Blood Calcium Concentrations
Condition: Autosomal Dominant Hypocalcemia (ADH)
Intervention: Drug: NPSP795

Indicates status has not been verified in more than two years